Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer.
Vaccine Research Market Expected To Achieve A Strong 8.13% CAGR, To Reach USD 128.02 Billion By 2032
Vaccine Research Market Governments and private entities are heavily investing in vaccine research and development.US, NY, UNITED STA ...
Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.
9don MSN
A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce ...
Radiation therapy is a powerful tool for fighting cancer, but it comes with painful side effects. About 60% of cancer ...
Johns Hopkins scientists develop mRNA "booster" as potential new way to treat rare genetic diseases marked by too low levels ...
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
announced today that it has completed its previously announced acquisition of Officinae Bio’s DNA and RNA business. This acquisition combines Officinae Bio's AI-enabled mRNA design platforms ...
"We are thrilled to bring Officinae into the Maravai family ... we intend to accelerate the field of next-generation medicines in mRNA and CRISPR, using best-in-class chemistries, processes ...
COVID-19 vaccines made by Pfizer and Moderna are both mRNA vaccines ... lacks a way to get into a cell’s nucleus to change it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results